Activation of this circuit in obese mice reduces food intake and improves glucose tolerance by stimulating insulin secretion via inhibition of GABA-input-dependent sympathetic nervous activity in the paraventricular hypothalamus
There are no studies that support microdosing as a method to maintain weight loss
By helping people limit compulsive eating and drinking, motivate movement, and reduce chronic inflammation, which we know GLP-1s can do, we promote a higher quality life. The latest science demonstrates that we should be thinking about GLP-1 medication differently, said Dr
GLP-1s, first approved for type 2 diabetes in 2005, lower blood glucose, help avoid fatty liver disease, and help with obesity-related problems such as knee pain, sleep apnea, and gastroesophageal reflux
Combining GLP-1 pathway medications with some other commonly used T2D medications (for example thiazolidinediones or sulfonylureas) may not have an additional benefit